# Tegafur + Gimeracil + Oteracil K

## TS-1 20mg

#### 本院臨採清單

| 藥品代碼       | OTS1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|:---------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症         | Post-op adjuvant chemotherapy for locally advanced [stage II (excluding T1)， IIIA or IIIB) gastric cancer.Treatment for advanced Inoperable or recurrent gastric cancer.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 用法用量       | In general， for adults， the initial dose is determined based on body surface area (BSA). BSA < 1.25 m2: 40 mg/dose (80 mg/day); BSA 1.25 to < 1.5 m2: 50 mg/dose (100 mg/day); BSA >= 1.5 m2: 60 mg/dose (120 mg/day). Administer TS-1 capsule orally twice daily， after breakfast and dinner， for 28 consecutive days (4 weeks)， followed by a 14-day (2 weeks) rest for a 6-week course. For colorectal cancer， TS-1 administered orally twice daily on days 1 through 14 of a 28-day cycle in combination with irinotecan 125 mg/m2 IVD once every 14 days on day 1 and 15. TS-1 must NOT be taken with other fluoropyrimidine-group anti-cancer drug. |
| 肝功能異常     | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 腎功能異常     | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 禁忌           | Severe bone marrow depression， renal & hepatic disorder. Treatment with other fluoropyrimidine-group anticancer drugs (including combination therapies) & flucytosine. Pregnancy & lactation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 副作用         | Leukopenia， decreased Hb， thrombocytopenia， decreased neutrophil count; increased AST/ALT， bilirubin & creatinine; glycosuria， stomatitis， anorexia， nausea， vomiting， diarrhea， abdominal pain， constipation， rash， pigmentation， lacrimation， taste abnormality， dizziness， decreased weight， pyrexia， nasopharyngitis & fatigue.                                                                                                                                                                                                                                                                                                          |
| 孕期用藥建議   | nan                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 哺乳期用藥建議 | Hold Breast Feeding 暫停哺乳                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |

